High Prevalence of ST502 Carrying an OXA-24 Carbapenemase gene in Carbapenem-Nonsusceptible Acinetobacter baumannii-calcoaceticus Isolates in Romania.
Erlangga YusufManuela TompaNikolaos StrepisCorné H W KlaassenWil H F GoessensPublished in: Microbial drug resistance (Larchmont, N.Y.) (2022)
Background: Acinetobacter baumannii can cause difficult-to-treat infections because it can acquire extensive antimicrobial resistance mechanisms. We aim to describe the antimicrobial resistance pattern and the genetic basis of carbapenem-nonsusceptible A. baumannii isolates in a University Hospital in Romania, a country where multidrug-resistant A. baumannii is widespread. Methods: We collected 104 consecutive meropenem-nonsusceptible A. baumannii isolates from 104 patients (36% female, mean age [SD] of 63 [16] years) between May 2015 and August 2017 from a large tertiary center in Romania. Whole-genome sequencing of representative isolates from amplified fragment length polymorphism clusters was used to determine clonality and resistance patterns. Results: All isolates were resistant to piperacillin/tazobactam, ceftazidime, and ciprofloxacin; 88.5% to gentamicin; and 90.4% to trimethoprim/sulfamethoxazole. In contrast, 79.8% and 99.0% were susceptible to tobramycin and colistin, respectively. The only isolate resistant to colistin had an minimum inhibitory concentration (MIC) of ≥16 mg/L. The bla OXA-24 gene was detected in 79.1% and bla OXA-23 in 20.9% of the isolates. In one isolate, bla OXA-23 was copresent with bla OXA-24 . ST502 (Oxford scheme) was the most prevalent sequence type and was exclusively associated with bla OXA-24 . Conclusions: ST502 associated with bla OXA-24 was frequently observed in the region where carbapenem-nonsusceptible A. baumannii was found to be endemic. In these isolates, tobramycin and colistin might be the remaining therapeutic options. Due to differences in gentamicin and tobramycin resistance in these isolates, surveillance data should not group gentamicin, tobramycin, and amikacin together as aminoglycosides.
Keyphrases
- multidrug resistant
- klebsiella pneumoniae
- acinetobacter baumannii
- gram negative
- antimicrobial resistance
- drug resistant
- genetic diversity
- pseudomonas aeruginosa
- end stage renal disease
- genome wide
- ejection fraction
- public health
- chronic kidney disease
- peritoneal dialysis
- copy number
- escherichia coli
- magnetic resonance imaging
- computed tomography
- patient reported outcomes
- dna methylation
- prognostic factors
- amino acid
- genome wide identification